...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** BETonMACE Phase 3 Cardio Outcomes Trial for Apabetalone Has Reached its Targeted 250 MACE Events ** Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155


BREAKING: Spyder Cannabis Announces Plans to Enter US Hemp Derived Market Through Rollout of Boutique Retail and Kiosk Stores

  • Newly Listed Spyder Cannabis $SPDR.ca Announces Phase 1 plan for locations in 4 states
  • Already an established Ontario retail operator
  • Partnering with developers & realtors for prime real estate high traffic areas (Malls, Sport Venues)

Spdr logo large

Hub On AGORACOM / Read Release

Message: Scenario Analysis on end of BETonMACE Phase 3

From where I sit Resverlogix does a horrible job of managing expectations....so I'm managing my own.  It seems pretty much everyone has taken the 250 Event milestone taking place in April....that "expectation" has been taken to the bank with the funds already designated for deposit.  

What happens if April rolls into May with no news?

Based on past experience I think it would be pretty naive to expect the company to be proactive with an announcement of any kind before hand.

Personally I will take any further delays as a positive.....


New Message
Please login to post a reply